David J Gibson (Dave J Gibson)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Ulcerative Colitis

Simultaneous Determination

Molecularly Imprinted

Clinical Evaluation

Top Venues

Alimentary pharmacology & therapeutics

Frontline gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

David J Gibson, Mayenaaz Sidhu, Simon Zanati, David J Tate, Dileep Mangira, Alan Moss, Rajvinder Singh, Luke F Hourigan, Spiro Raftopoulos, Alan Pham, Phil Kostos, M Priyanthi Kumarasinghe, Andrew Ruszkiewicz, Duncan McLeod, Gregor J E Brown, Michael J Bourke
Oncological outcomes after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps with covert submucosal invasive cancer. Gut 71 (12) (2022)
David J Gibson, Mark G Ward, Clarissa Rentsch, Antony B Friedman, Kirstin M Taylor, Miles Patrick Sparrow, Peter R Gibson
Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 51 (6) (2020)
David J Gibson, Jayne Doherty, Mairead McNally, John Campion, Denise Keegan, Aine Keogh, Una Kennedy, Kathryn Byrne, Laurence J Egan, Susan McKiernan, FInbar MacCarthy, Subhasish Sengupta, Juliette Sheridan, Hugh E Mulcahy, Garret Cullen, Eoin Slattery, David Kevans, Glen A Doherty
Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction. Frontline gastroenterology 11 (6) (2019)
David J Gibson, Mark G Ward
Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy-early promise but more data needed. Alimentary pharmacology & therapeutics 49 (6) (2019)